hotspot -WSS

hotspot

author：knowledge 2025-10-01 10:59:31 - browse：759

Illustration: Alex Hogan/STAT; Photo: Courtesy Perrigo

It’s not every day that a marketing team is tasked with designing the branding and packaging of the first over-the-counter birth control pill to be sold in the U.S.

This was the challenge, and the opportunity, faced by the team behind Opill, the landmark pill from drugmaker Perrigo that received approval from the Food and Drug Administration earlier this month. Their brief: Create a design that would stand out in America’s notoriously sprawling pharmacy aisles; inspire trust and confidence; be easy to remember and recognize; appeal to women — including teenagers — as well as trans men and nonbinary people; clearly communicate its purpose; be simple to carry and use; contain straightforward but accurate user information; and clear FDA requirements.

Settling on the right approach took years of research and testing, which resulted in the name Opill and packaging featuring bright teal, saturated pink, and yellow, as well as a rounded font reminiscent of millennials’ ubiquitous favorite Gotham. All of these features are intended to set the product apart from the dozens of prescription contraceptive pills available in the U.S. market and internationally.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Poor hospice wound care hurts patients and families

WSS

Poor hospice wound care hurts patients and families

Charles Manson follower Leslie Van Houten released from prison after 53 years

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Astellas still sees hope in its gene therapy after four deaths

Study: Pain burden is higher in Black NFL players than white ones

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

explore

hotspot

knowledge

Walensky prepares to leave CDC — and Congress — behind

Biden launches a new push to limit health care costs

State Dept. review finds Biden bears some blame for Afghanistan failures

Retired US general questions alleged Putin, Prigozhin meeting

Medicare details structure of new drug price negotiation program

Study: Pain burden is higher in Black NFL players than white ones

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Congress must reauthorize a committee to support older Americans

Alkermes shareholders re

Anthos stroke drug appears safer than common blood thinner

entertainment

World's first CRISPR

NYU radiologists take on the challenge of expensive MRI machines

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

FDA's Woodcock to retire early next year

In key trial, Verve's treatment lowers cholesterol levels in patients

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

entertainment

hotspot

explore

Wikipedia